Header Logo

Connection

ALEXIS SHAFII to Humans

Back to Details
This is a "connection" page, showing publications ALEXIS SHAFII has written about Humans.
ALEXIS SHAFII
Connection Strength
0.327
Humans
  1. Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall. J Thorac Cardiovasc Surg. 2022 06; 163(6):2129-2130.
    View in: PubMed
    Score: 0.019
  2. Simple Felt-Plug Closure Technique for Minimally Invasive Removal of a Centrifugal-Flow Left Ventricular Assist Device. Tex Heart Inst J. 2020 08 01; 47(4):322-324.
    View in: PubMed
    Score: 0.018
  3. Does Overtreatment of Heart Transplantation Candidates Exist? J Am Coll Cardiol. 2018 08 07; 72(6):702-703.
    View in: PubMed
    Score: 0.015
  4. Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case Report. Transplant Proc. 2017 Sep; 49(7):1682-1684.
    View in: PubMed
    Score: 0.014
  5. Too high for transplantation? Single-center analysis of the lung allocation score. Ann Thorac Surg. 2014 Nov; 98(5):1730-6.
    View in: PubMed
    Score: 0.012
  6. Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation. ASAIO J. 2012 Sep-Oct; 58(5):526-9.
    View in: PubMed
    Score: 0.010
  7. Subclavian insertion of the bicaval dual lumen cannula for venovenous extracorporeal membrane oxygenation. Ann Thorac Surg. 2012 Aug; 94(2):663-5.
    View in: PubMed
    Score: 0.010
  8. High incidence of upper-extremity deep vein thrombosis with dual-lumen venovenous extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):988-9.
    View in: PubMed
    Score: 0.010
  9. Changes in left ventricular morphology and function after mitral valve surgery. Am J Cardiol. 2012 Aug 01; 110(3):403-408.e3.
    View in: PubMed
    Score: 0.010
  10. Fate of retained right ventricular assist device outflow grafts after right ventricular recovery. J Heart Lung Transplant. 2012 Jun; 31(6):672-3.
    View in: PubMed
    Score: 0.010
  11. Total arch replacement after a failed repair for Takayasu's ascending aortitis. Ann Thorac Surg. 2012 Jan; 93(1):300-2.
    View in: PubMed
    Score: 0.010
  12. Coincidental alignment of extracorporeal oxygenator cannula and central venous catheter. Ann Thorac Surg. 2011 Oct; 92(4):1529.
    View in: PubMed
    Score: 0.010
  13. Omental flap transposition with intra-abdominal relocation for LVAD pump-pocket infection. J Heart Lung Transplant. 2011 Dec; 30(12):1421-2.
    View in: PubMed
    Score: 0.010
  14. The effect of recipient hepatitis C virus infection on outcomes following heart transplantation. Transplant Proc. 2010 Jun; 42(5):1784-7.
    View in: PubMed
    Score: 0.009
  15. Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported With CF-LVADs? Artif Organs. 2026 Jun; 50(6):886-890.
    View in: PubMed
    Score: 0.006
  16. Predicting Sepsis in Heart Failure Patients Supported by Left Ventricular Assist Devices: The Role of VE-Cadherin and ADAM10. Int J Mol Sci. 2026 Jan 06; 27(2).
    View in: PubMed
    Score: 0.006
  17. Driveline Infections Among Patients Supported With Left Ventricular Assist Devices: A Single Center Sixteen-Year Longitudinal Profile. Artif Organs. 2026 Apr; 50(4):572-579.
    View in: PubMed
    Score: 0.006
  18. Preoperative brain volume loss is associated with postoperative delirium in advanced heart failure patients supported by left ventricular assist device. Sci Rep. 2025 Mar 14; 15(1):8884.
    View in: PubMed
    Score: 0.006
  19. Endostatin and Cystatin C as Predictors of 1 Month Renal Function Change in Patients With Left Ventricular Assist Device Support. ASAIO J. 2025 10 01; 71(10):785-794.
    View in: PubMed
    Score: 0.006
  20. Machine Learning Assisted Stroke Prediction in Mechanical Circulatory Support: Predictive Role of Systemic Mitochondrial Dysfunction. ASAIO J. 2025 05 01; 71(5):387-394.
    View in: PubMed
    Score: 0.006
  21. Effect of Preoperative Mitral Regurgitation on LVAD Outcomes in Patients with Elevated Pulmonary Vascular Resistance. Cardiovasc Drugs Ther. 2025 10; 39(5):1085-1095.
    View in: PubMed
    Score: 0.006
  22. Minimally Invasive Mitral Valve Surgery Using a Cold Fibrillatory Cardiac Arrest Technique in Patients With Prior Cardiac Surgery. Tex Heart Inst J. 2024 07 19; 51(2).
    View in: PubMed
    Score: 0.006
  23. Risk Factors, Incidence, and Outcomes Associated With Clinically Significant Airway Ischemia. Transpl Int. 2024; 37:12751.
    View in: PubMed
    Score: 0.006
  24. Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
    View in: PubMed
    Score: 0.006
  25. Incidence, Risk Score Performance, and In-Hospital Outcomes of Postoperative Atrial Fibrillation After Cardiac Surgery. Tex Heart Inst J. 2023 10 25; 50(5).
    View in: PubMed
    Score: 0.005
  26. Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy. Tex Heart Inst J. 2023 08 22; 50(4).
    View in: PubMed
    Score: 0.005
  27. COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. J Heart Lung Transplant. 2023 01; 42(1):33-39.
    View in: PubMed
    Score: 0.005
  28. Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. 2023 Dec; 26(4):275-286.
    View in: PubMed
    Score: 0.005
  29. Extracorporeal Membrane Oxygenation for COVID-19: Collaborative Experience From the Texas Medical Center in Houston With 2 Years Follow-Up. ASAIO J. 2022 12 01; 68(12):1443-1449.
    View in: PubMed
    Score: 0.005
  30. Preoperative hyponatremia and survival after left ventricular assist device implantation. Artif Organs. 2022 Sep; 46(9):1923-1931.
    View in: PubMed
    Score: 0.005
  31. Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022 Mar; 25(1):16-23.
    View in: PubMed
    Score: 0.005
  32. Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs. 2021 Jun; 24(2):207-216.
    View in: PubMed
    Score: 0.005
  33. Increasing Heart Transplant Volume by Expansion of Donor Heart Selection Criteria: A Single-Center Analysis. Transplant Proc. 2020 Apr; 52(3):949-953.
    View in: PubMed
    Score: 0.004
  34. Left Ventricular Assist Device Outflow Graft Obstruction: A Complication Specific to Polytetrafluoroethylene Covering. A Word of Caution! ASAIO J. 2019 08; 65(6):e58-e62.
    View in: PubMed
    Score: 0.004
  35. Outcomes of Lung Transplantation for Cystic Fibrosis in the Setting of Extensively Drug-Resistant Organisms. Prog Transplant. 2019 09; 29(3):220-224.
    View in: PubMed
    Score: 0.004
  36. Early signatures of bleeding and mortality in patients on left ventricular assist device support: novel methods for personalized risk-stratification. Biomarkers. 2019 Jul; 24(5):448-456.
    View in: PubMed
    Score: 0.004
  37. Impact of donor lung pathogenic bacteria on patient outcomes in the immediate post-transplant period. Transpl Infect Dis. 2018 Dec; 20(6):e12986.
    View in: PubMed
    Score: 0.004
  38. Increased blood transfusion and its impact in patients having tracheostomy while on extracorporeal membrane oxygenation. Perfusion. 2019 03; 34(2):143-146.
    View in: PubMed
    Score: 0.004
  39. Expanding the donor pool: donation after cardiac death. Thorac Surg Clin. 2015; 25(1):35-46.
    View in: PubMed
    Score: 0.003
  40. Clinical and morphologic features of acute, subacute and chronic cor pulmonale (pulmonary heart disease). Am J Cardiol. 2015 Mar 01; 115(5):697-703.
    View in: PubMed
    Score: 0.003
  41. Spectroscopic limb monitoring in peripheral extracorporeal membrane oxygenation. Asian Cardiovasc Thorac Ann. 2015 Mar; 23(3):347-8.
    View in: PubMed
    Score: 0.003
  42. Which is better: a miniaturized percutaneous ventricular assist device or extracorporeal membrane oxygenation for patients with cardiogenic shock? ASAIO J. 2013 Nov-Dec; 59(6):607-11.
    View in: PubMed
    Score: 0.003
  43. Case series using the ROTAFLOW system as a temporary right ventricular assist device after HeartMate II implantation. ASAIO J. 2013 Jul-Aug; 59(4):456-60.
    View in: PubMed
    Score: 0.003
  44. Pathologic correlates of heparin-free donation after cardiac death in lung transplantation. J Thorac Cardiovasc Surg. 2013 May; 145(5):e49-50.
    View in: PubMed
    Score: 0.003
  45. Combined heart and liver transplantation: the Cleveland Clinic experience. Ann Thorac Surg. 2013 Jan; 95(1):179-82.
    View in: PubMed
    Score: 0.003
  46. Outcomes of axillary artery side graft cannulation for extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2013 Apr; 145(4):1088-1092.
    View in: PubMed
    Score: 0.003
  47. Donor lungs with pulmonary embolism evaluated with ex vivo lung perfusion. ASAIO J. 2012 Jul-Aug; 58(4):432-4.
    View in: PubMed
    Score: 0.003
  48. Spontaneous coronary artery dissection in Ehlers-Danlos syndrome. Ann Thorac Surg. 2011 Nov; 92(5):1883-4.
    View in: PubMed
    Score: 0.002
  49. Images in cardiology. Ventricular outflow tract papillary fibroelastoma presenting with non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2010 Jun 08; 55(23):2607.
    View in: PubMed
    Score: 0.002
  50. TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo. Am J Surg. 2005 Jun; 189(6):675-9.
    View in: PubMed
    Score: 0.002
  51. MMP-2 and TIMP-1 are derived from, not in response to, pancreatic cancer. J Surg Res. 2002 Jan; 102(1):35-8.
    View in: PubMed
    Score: 0.001
  52. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. J Surg Res. 2002 Jan; 102(1):39-44.
    View in: PubMed
    Score: 0.001
  53. Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer. J Gastrointest Surg. 2000 Nov-Dec; 4(6):614-9.
    View in: PubMed
    Score: 0.001
  54. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer. Cancer Res. 2000 Jun 15; 60(12):3207-11.
    View in: PubMed
    Score: 0.001
  55. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer. J Surg Res. 1999 Jan; 81(1):65-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.